Daewon Pharmaceutical Co., Ltd.   Report issue

Founded: Seoul Korea, Republic of (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2010
NCT01781702
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Daewon Pharmaceutical Co., Ltd.